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Background: A home based tele-monitoring system was developed to assess the effects of heat stress (days > 25°C)
on clinical and functional status in patients with chronic obstructive pulmonary disease (COPD).
Methods: Sixty-two COPD patients (GOLD II–IV) were randomized into a tele-monitoring Group (TG, N = 32) or Control
Group (CG, N = 30). Tele-monitoring included 1) daily clinical status (COPD Assessment Test-CAT), 2) daily lung function
and 3) weekly 6-minute walk test (6MWT). Duration of monitoring lasted a total of nine months (9 M).
Results: From June 1st–August 31st 2012, 32 days with heat stress (29.0 ± 2.5°C) were recorded and matched with 32
thermal comfort days (21.0 ± 2.9°C). During heat stress, the TG showed a significant reduction in lung function and
exercise capacity (FEV1% predicted: 51.1 ± 7.2 vs. 57.7 ± 5.0%; P <0.001 and 6MWT performance: 452 ± 85 vs. 600 ± 76
steps; P <0.001) and increase in CAT scores (19.2 ± 7.9 vs. 16.2 ± 7.2; P <0.001).
Over summer, significantly fewer TG patients suffered exacerbation of COPD compared to CG patients (3 vs. 14; P = 0.006).
Over entire 9 M follow-up, the TG group had fewer exacerbations compared to CG (7 vs. 22; P = 0.012), shorter cumulative
hospital stay (34 vs. 97 days) and 43% fewer specialist consultations (24. vs. 42; P = 0.04).
Conclusion: Heat stress affects clinical and functional status in COPD. Tele-monitoring reduces exacerbation frequency
and health care utilization during heat stress and other periods of the year.
Trial registration: DRKS-ID: DRK00000705.
Keywords: Climate change, Telemedicine, Heat stress, Exacerbation frequency, Activity monitoringBackground
The effects of climate change and global warming on
human health, in particular in patients with lung disease,
are poorly understood at present. The lung is of particu-
lar interest in this context, because it can be seen as the
portal organ of the environment. For this reason, chronic
obstructive pulmonary disease (COPD) is an ideal disease
model to help us comprehend the dynamics between
human health and climate change [1].
The incidence and prevalence of COPD is rapidly in-
creasing and experts predict it to be the third leading
cause of mortality worldwide [2]. Depending on disease* Correspondence: melissa.jehn@charite.de
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stated.severity, patients suffer from mild to severe airflow limi-
tations associated with an accelerated decline related
lung function [3]. One of the most prominent causes for
hospital admissions in older patients is acute exacerbation
of COPD (AECOPD) and previous research suggests
that this condition is aggravated by extreme temperatures
[2,4,5]. AECOPD is characterized by a sudden worsening
of respiratory symptoms such as shortness of breath,
sputum production, coughing and wheezing. Clinical mani-
festations of AECOPD include increased airway inflam-
mation, reduced expiratory air flow and worsening of gas
transfer [6].
There is abundant epidemiological data showing increased
morbidity and mortality rates during heat waves in patients
with respiratory diseases, including COPD [7-10]. Neverthe-
less, little is known about the clinical and lung functionald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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(> 65 years of age) with COPD experience a heightened
medical vulnerability to heat stress, because lung perfu-
sion and bronchial mucosa are negatively affected by hot
air loaded with air pollutants [11]. In addition, the control
of cutaneous blood flow and the ability to sweat is com-
promised in the elderly, as well as an inability to perceive
changes in heat and thus adjust behavioral responses
i.e. by increasing fluid intake [12,13]. Heat intolerance
is further augmented by chronic medication use and
additional comorbidities such as cardiovascular disease
[7,10]. During heat stress, dilation of peripheral bloods
vessels requires the heart to work harder to maintain
central blood pressure, a problem which is possibly worse
with heart failure, a common co-morbidity in patients
with COPD [14]. The increased cardiac work and tachy-
cardia may increases the sensations of breathlessness
and make the perception of exacerbation more likely
[15-17]. Evidence has shown that elderly patients with
COPD are at greater risk for exacerbation of COPD
if the following social and/or working factors apply:
1) living alone, 2) confined to the house, 3) have poor
social contact, 4) poverty, 5) no access to transportation,
6) no green space and 7) no working fan or air condi-
tioning use [11].
According to climate change projections, the risk for
heat exposure will continue to increase due to the in-
creased frequency, longer duration and greater intensity
of hot spells [18,19]. Targeted adaptation strategies are
needed in order to counteract upcoming health hazards,
in particular in patients with advanced COPD. The
multidisciplinary German Federal Research Program
KLIMZUG, “Klima in Regionen zukunftsfähig gestalten”
aims to investigate adaptation strategies to climate change
in different regions of Germany. One of the main working
packages of this project is dedicated to climate change
and public health, and in particular, evaluation of vulner-
ability to heat stress of patients with chronic obstructive
pulmonary disease (COPD) in Berlin, Germany, a metropol-
itan area surrounded by the countryside of Brandenburg
(Trial registration: URL: https://drks-neu.uniklinik-freiburg.
de/drks_web/; ID: DRK00000705). Primary and second-
ary study endpoints of this project include 1) determin-
ation of how heat stress exposure influences clinical
status and functional capacity and 2) development and
evaluation of a home based tele-monitoring system for
COPD patients to investigate whether it reduces the risk
of exacerbation during and outside periods of heat stress.
Methods
Patient recruitment took place between Jan–April 2012
with study duration of nine months. To be eligible for the
study, patients had to be diagnosed with COPD Stage II-
IV on the basis of a clinical history such as smoking status,physical examination and meet the post-bronchodilator
spirometric criteria according to the GOLD guidelines
(FEV1 < 80% predicted & FEV1/FVC ratio <0.7). Spirom-
etry was performed by trained lung function technicians
according to American Thoracic Guidelines [6]. Patients
also had to have at least one exacerbation during the
previous year, be ≥ 40 years of age and clinically stable
for the four weeks prior to inclusion. Patients were
excluded from the study if they suffered from 1) asthma,
2) required long-term oxygen therapy, 3) had severe heart,
liver or kidney disease, 4) any end stage malignant disease
with life expectancy of less than six months, 5) were listed
for a lung transplant, 6) had severe depression, 7) were
residents in a nursing home, 8) had any physical disabil-
ities limiting them from performing a six minute walk test
(6MWT) and/or 9) were mentally disabled.
Acute exacerbation of COPD (AECOPD) was defined
according to significant worsening of respiratory symp-
toms requiring change in medication (oral corticosteroids
and/or antibiotics) and the presence of at least one of
the following items: 1) increased dyspnea, 2) increase in
the amount of sputum production and 3) change in spu-
tum purulence [20]. Primary diagnosis of acute exacer-
bation of COPD was done by the treating physician in
the emergency room and later confirmed by the study
physician. All exacerbations in this study analysis
were defined as a minimum of ≥ 24 hour hospital stay–
duration time.
Patients were randomized into either a Telemedicine
group (TG) who participated in a tele-monitoring inter-
vention or a control group (CG). Both groups also re-
ceived usual care which was based on current guidelines
for the treatment and management of COPD and included
an initial baseline examination and regular follow-up visits
at 3, 6, and 9 M. At these visits, a detailed medical history,
current medication, duration of disease, co-morbidities,
physical examination, height, quality of life (SGRQ [21]),
modified Medical Research Council Dyspnoea Scale
(mMRC), spirometry, CAT, and 6MWT distance assessed
with a distance measuring wheel as well as the number
of steps taken during the 6 minutes (6MWT step count)
assessed via accelerometry were recorded. Patients were
also asked about the number of visits to their primary
care physician or lung specialist.
The tele-monitoringintervention included 1) daily assess-
ment of clinical status by means of the COPD Assessment
Test (CAT), 2) daily lung function testing (spirometry),
and 3) a weekly six-minute walk test measured by accel-
erometry. Telemedicine group patients completed all
three testing modalities in their home-based environ-
ment. Following completion of the tests, patient data
were transmitted via a mobile network directly to the
study center at the Charité University Hospital, in Berlin.
Patients were asked to complete all measurements in the
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following inhalation of their usual bronchodilators.
Patients were thoroughly trained how to use all tech-
nical equipment during their baseline visit. A study nurse
was available during regular business hours five days per
week to provide first-line technical support in order to
ensure correct handling of the devices and continuous
data transmission. The study nurse also contacted patients
if data was not sent during the agreed time window to
remind patients to complete the tests if necessary; for
safety reasons incoming data was reviewed by the study
physician on a daily basis, however data was gathered in
an observational manner.
The study was carried out according to the princi-
ples of the Declaration of Helsinki and approved by
our local ethics committee “Ethikkommission Charité -
Universitätsmedizin Berlin” (Ethic Number EA1/033/10).
Written informed consent was obtained from all patients.
Tele-monitoring system
1. COPD assessment test (CAT)
The CAT (© 2009 GlaxoSmithKline) is directly entered
into the mobile medical assistant (PDA system, MMA
400, Aipermon GmbH & Co. KG, Munich, Germany) by
the patients. This assessment test is composed of eight
questions each containing a scale from 0 (= never) to 5
(= always). Question 1: asks coughing frequency, question
2: level of congestion (sputum), question 3: tightness in
the chest, question 4: exercise induced dyspnea, question
6: degree of functional impairment during routine ac-
tivities, question 7: quality of sleep, and question 8: level
of energy.
2. Assessment of lung function
Lung function was measured with a hand held spirom-
eter (Vitalograph asma-1 BT, Aipermon GmbH & Co.
KG, Munich, Germany). Patients were asked to perform
each measurement in a seated position, hold a maximal
inhalation, place the plastic mouthpiece of the spirometer
into the mouth and exhale as forcefully and as fast as
possible for at least six seconds. The following lung
function parameters are displayed on the screen in sub-
sequent order: peak expiratory flow (PEF), forced expira-
tory volume in (ml) in one second (FEV1), forced expiratory
volume in six seconds (FEV6) and forced expiratory flow
25–75% (FEF25-75). The patients were instructed to repeat
this breathing maneuver three times in a row and the best
of three measurements was then transmitted to the study
center at the university hospital. Only FEV1 as a percentage
of a normal value predicted from age, gender and height
was used for statistical analysis.3. Assessment of weekly exercise capacity
Exercise capacity was assessed in form of the six-minute
walk test (6MWT) measured by a distance wheel (model:
Draper Expert Measuring Wheel) and accelerometry
(AiperMotion 300 PfH, Aipermon GmbH & Co. KG,
Munich, Germany). The study nurse trained the patients
in the test procedure, and instructed them to conduct
the 6MWTs on their own in their outdoors environment
using a flat walking path that would allow them to walk
continuously for six minutes without interruption. To
assure consistency, patients were asked to use the same
walking path throughout the nine-month intervention
period. The AiperMotion 300 device is a three dimen-
sional accelerometer customized especially for recording
data during the 6MWT with a “start 6MWT” button
and automatic end of data recording after 6 minutes.
The accelerometer is matchbox sized and worn on hip
level attached to the belt via a pocket pouch. Data out-
put includes the number of total steps taken, distance
and walking speed in six minutes. Measurement accuracy
of the device has been previously validated in patients
with chronic heart failure under laboratory conditions
as well as in a field based setting during which the validity
of 6MWT steps was established to be a suitable measure
of functional exercise capacity [22].
Assessment of temperature data
Data regarding daily temperature in degree Celsius were
obtained from the local weather station (Tempelhof, Berlin,
Germany; maintained by the Deutscher Wetterdienst)
and included daily temperature readings (Tempmean,
Tempmax, Tempmin), air pressure (hPa) and humidity (%).
This weather station is located 48 m above NN on 52.47° N
13.4° E. Days with Tempmax > 25°C were considered “heat
stress days”, whereas days with Tempmax ≤ 25°C were
regarded as “thermal comfort days”.
Statistical analysis
Statistical analysis was performed using SPSS software
(version 21.0, SPSS Inc.). Normally distributed data are
reported as mean ± standard deviation (SD) or median ± .
inter-quartile range, or as percentages for dichotomous
variables. Differences were compared using two-tailed
t test for normally distributed variables and Chi2-test
for dichotomous variables. P-values less than 0.05 were
considered statistically significant. From June 1st–August
31st 2012, 32 heat stress days were recorded and matched
with 32 thermal comfort days. Days with thermal comfort
were randomly chosen during the respective summer
months. Box blots were used to illustrate the dynamics
between daily patient measurements and temperature
data and dual axis bar plots were used to illustrate the
influence of daily temperature on clinical parameters.
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of exacerbations requiring hospitalizations and outpatient
consultation to the lung specialist and primary care
physician. Only the intention to treat population was
analyzed.Results
Patient characteristics
Sixty-two patients with COPD were included in this current
study analysis (TG, N = 32; CG N = 30) with moderate
to very severe disease (GOLD II, N = 25; GOLD III, N = 25,
GOLD IV, N = 12). Their mean age was 65.7 ± 10.3 years
and 74% were men; most patients were taking a long
acting anticholinergic agent (76%) and a long-acting
beta-2 agonist/inhaled corticosteroid combination (71%).
There were no statistically significant differences in
baseline characteristics between the TG and the CG (see
Table 1).Telemedical patient data
Summer period (June 1st–August 31st)
Heat stress days with thermal discomfort as defined by
the German Weather Service reached an average Tempmax
of 29.0 ± 2.5°C. Thermal comfort days reached an average
Tempmax of 21.0 ± 2.9°C. There was a significant differ-
ence (P < 0.001) in functional performance and clinical
status on “heat stress days” versus “thermal comfort days”,Table 1 Patient baseline characteristics (N = 62)
Group TG CG P-Value
N 32 30
Gender (male/female) 26/6 22/8 .79
Age (years) 64.1 ± 10.9 69.1 ± 9.2 .27
BMI (kg/m2) 27.6 ± 6.7 27.0 ± 4.9 .87
Resting SpO2 Saturation 95.4 ± 1.7 94.3 ± 3.6 .095
FEV1 (%) 50.2 ± 15.0 52.6 ± 17.5 .731
PEF (L/min) 3.7 ± 1.23 4.4 ± 1.4 .194
MMRC 1.9 ± 1.1 1.2 ± 0.93 .125
GOLD 2.6 ± 0.8 2.5 ± 0.9 .83
BODE 3.2 ± 3.1 2.9 ± 3.0 .55
SGRQ 51.3 ± 18.7 48.7 ± 14.7 .56
COPD Medication
Long AC 25 (78%) 22 (73%) .33
ICS/LABA 23 (72%) 21 (70%) .46
Characteristics of patient population; data is presented as Mean ± SD; group
comparisons of measurements across between Tele-monitoring group (TG) and
control group (CG) were done using a two tailed student’s t-test and χ2-test.
BMI = Body Mass Index; SpO2 = resting oxygen saturation; FEV1 (L) = Forced
Expiratory Volume in one second; PEF = Peak Expiratory Flow; MMRC =Modified
Medical Research Council Dyspnea Scale; SGRQ = St. George Respiratory
Questionnaire; Long AC = Long Acting Anticholinergic; ICS/LABA = fix
combination of ICS/LABA.with a marked decrease in FEV1 (Mean difference: –6.6 ±
6.1%) and 6MWT performance (Mean difference: -48.0 ±
80 steps), as well as a concomitant increase in CAT score
(Mean difference: + 3.0 ± 7.6 points) (see Table 2 and
Figure 1a-c). Day to day variations in clinical parameters
in response to outside temperature fluctuations for the
months June–August 2012 are depicted in Figure 2a and b.Clinical outcome of study population
Summer period (June 1st–August 31st)
Significantly fewer TG patients suffered exacerbation
of COPD during the summer period compared to CG
patients (3 for TG vs. 14 for CG; P = 0.006). Tempmax
on days of exacerbation reached an average of 32.6 ±
2.0°C and atmospheric ozone levels of 130.3 ± 20.1 mg/m3
(see Figure 3). Patients that suffered exacerbation of
COPD on heat stress days tended to be male, slightly
older in age (mean age: 70 ± 5.6 years), have higher BMI
(27.5 ± 3.3 kg/m2), lower FEV1% predicted (38.2 ± 8.1%)
and higher number of co-morbidities (Charlson Index:
2.9 ± 1.0) than patients that suffered exacerbation during
other months of the year but these differences were not
statistically significant.Over 9-month follow-up
Overall the TG showed a significantly lower number of
exacerbation related hospital admissions over the 9 M
follow-up time compared to the CG (7 for TG vs. 22 for
CG; P = 0.012), significantly fewer visits to the lung
specialist (24 for TG vs. 42 visits for CG; P = 0.042) and
slightly fewer visits to the primary care physician (9 for
TG vs. 11 visits for the CG; P = 0.76) (see Figure 4). In
addition, patients in the TG spent significantly less cu-
mulative time in hospital due to COPD complications
compared to the CG (34 days versus 97 days).Table 2 Remote patient data: “Heat stress” days vs.
“Thermal comfort” days
Temperature Tempmax > 25°C Tempmax ≤ 25°C P-value
N 32 32
Tempmax °C 29.0 ± 2.5 21.0 ± 2.9 < 0.001*
Tempvariance K 13.5 ± 3.0 12.0 ± 2.4 0.017*
Air Humidity (%) 58.8 ± 13.7 60.8 ± 9.6 0.517
Air Pressure (hPa) 1008 ± 4.5 1009 ± 11.4 0.769
6MWT steps 452 ± 85 600 ± 76 < 0.001*
FEV1 (%) 51.1 ± 7.2 57.7 ± 5.0 < 0.001*
CAT score 19.2 ± 7.9 16.2 ± 7.2 < 0.001*
Remote patient data on days with heat stress vs. thermal comfort days. Data
is expressed as means ± SD. Comparisons are made via paired student’s t-test;
*statistical significance is set at P < 0.05; Please see Table 1 for all other
abbreviations.
Figure 1 Clinical and functional status on days with heat stress
vs. thermal comfort. Box plots showing a) CAT Score, b) FEV1 (%) and
c) 6MWT steps on 32 days with Tempmax > 25°C compared to 32 days
with Tempmax ≤ 25°C. Statistical significance is set at P < 0.05.
Figure 2 Variation in daily clinical status and lung-function in
response to outside temperature. Dual axis box plots with the x-axis
depicting a) FEV1 (ml) and b) CAT score. The y-axis indicates the
days from June–31st August and the z-axis (black line) shows daily
temperature fluctuations.
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improvement in clinical status between BL and 9 M follow-
up (Mean Difference in CAT score: -2.9 ± 4.5; P = 0.04),
in contrast to the CG group in whom clinical status
worsened in this time (Mean Difference in CATscore: +4.4 ± 5.7; P = 0.013). The TG group also showed a
significant improvement in 6MWT distance between BL
and 9 M follow-up (Mean Difference in 6MWT: +87.0 ±
65.7 metres, P = 0.006), whereas the CG group showed no
significant change (Mean Difference in 6MWT: +23.9 ±
70.3 metres, P = 0.23). Spirometry remained unchanged
in both groups between BL and 9 M follow-up. Between
both groups, only the change in CAT score was significantly
different between BL and 9 M follow-up (P = 0.001). See
Table 3.
Exacerbation vs. event free patients
Patients that suffered an exacerbation had significantly
lower FEV1% at BL compared to patients that remained
event free (44.2 ± 13.1% vs. 57.2 ± 20.2%, respectively;
P = 0.045) and significantly lower BL exercise capacity
(6MWT steps: 450 ± 87.3 steps vs. 537 ± 91.2 steps;
Figure 3 Bar graph showing the number of exacerbation from
June–August 2012 in the Telegroup (TG = grey boxes, N = 3) and
the Control Group (CG= black boxes, N = 14) with corresponding
date of event on the x-axis and daily Tmax in °C on the y-axis.
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Table 1 showed any significant difference between patients
with exacerbation and patients that remained event free.
Discussion
We have several findings to report from this study:
1) Clinical status, lung function and exercise capacity are
negatively affected by heat stress in patients with COPD.
By means of continuous tele-monitoring we were able
to show significant worsening in all three parametersFigure 4 Bar graph representing number of exacerbations
(light grey), visits to the primary care physician (medium grey)
and to the lung specialist (dark grey) in the Telegroup (TG, N = 32)
versus the Control Group (CG, N = 30). Statistical significance is
set at P < 0.05.on heat stress days compared to thermal comfort days
during the summer period. 2) Heat stress aggravates
COPD symptoms putting patients at greater risk for
exacerbation of COPD. Tele-monitoring seems to reduce
the risk of exacerbation during the summer period.
3) Continuous tele-monitoring improves clinical and
functional status of COPD patients over time and re-
duces the frequency of exacerbation and health care
utilization during all periods of the year.
Previous investigators have reported on the impact of
heat stress in elderly COPD patients, [10,11,23], however
these studies have focused primarily on epidemiological
data in terms of morbidity and mortality rates [1,9,24,25].
To the best of our knowledge, this is the first study that
has looked at changes in physiologic parameters in re-
sponse to outside temperature in patients with COPD.
With the help of continuous tele-monitoring during the
summer months, we were able to investigate the direct
effect heat stress has on health status in our patient co-
hort. Our data show that heat stress negatively impacts
patients’ functional capacity and clinical status including
exacerbation of COPD. Our data also show that tele-
monitoring reduced the incidence of exacerbation of COPD,
both in the summer and over the 9 month study period.
Although we cannot be sure that summer exacerbations
are directly caused by heat stress in our patient cohort,
we did observe that tele-monitoring reduces the risk of
exacerbation, heat related or not. Therefore it seems
beneficial to implement tele-monitoring in vulnerable
patient groups during prolonged heat exposure.
A recent study by Jensen et al. also looked at the
overall benefits of tele-monitoring in COPD patients and
reported similar findings to ours in terms of clinical out-
come and disease management [26]. We agree with the
conclusions made by Jensen et al., in that the overall
improvements seen in COPD patients are to the most
part attributable to the continuous task of home based
testing. It brings patients into closer contact with their dis-
ease by enhancing disease awareness and self-management
skills. Other studies have also demonstrated a signifi-
cant reduction in hospital utilization in COPD patients
using self-management programms [27-29]. A study by
Vitacca et al. was able to show a 50% reduction in health
care expenditure per COPD patient managed by tele-
monitoring compared to patients receiving usual care
only [30].
What makes our tele-monitoring system novel in com-
parison to other telemedical studies in COPD is that we
included the element of weekly exercise testing via accel-
erometry. Our data show that this approach is feasible
and safe in patients with COPD. We still believe that
improvements in our TG patients are driven by enhanced
disease awareness on the patients’ side; however, it is pos-
sible that the weekly 6MWT elicited a slight “exercise
Table 3 Baseline compared to 9 month Follow-up visit
Group Telegroup, N = 27 P-value Control group, N = 25 P-value
BL 9 M Mean difference BL 9 M Mean difference
6MWT steps 522 ± 113 662 ± 86.4 140 ± 95.2 0.006* 553 ± 103 601 ± 88.7 48.3 ± 85.2 0.23
6MWT distance 377 ± 88.0 464 ± 60.5 87.0 ± 65.7 0.006* 377 ± 78.0 400 ± 72.4 23.9 ± 70.3 0.23
FEV1% 50.2 ± 15.0 52.7 ± 16.7 2.5 ± 5.2 0.10 52.6 ± 17.4 52.6 ± 19.8 -.07 ± 9.2 0.99
CAT 19.0 ± 6.9 16.0 ± 5.6 −2.9 ± 4.5 0.04* 17.6 ± 5.0 22.0 ± 6.9 4.4 ± 5.7 0.013*
Characteristics of patient population baseline (BL) compared to 9-month follow-up; data is presented as Mean ± SD; group comparisons of measurements across
different Randomization Groups were done using a paired student’s t-test; *statistical significance is set at P ≤ 0.05. 6MWT = 6-minute walk test; FEV1 (%) = Forced
Expiratory Volume in one second% predicted; CAT = COPD Assessment Test.
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in otherwise sedentary COPD patients. It is also possible
that the weekly 6MWT promoted participation in other
recreational activities in our patient cohort thereby put-
ting patients more in touch with their physical boundaries.
Studies have shown that regular physical activity increases
exercise tolerance, reduces dyspnea, fatigue, anxiety and
depression in patients with COPD [31]. In addition regu-
lar exercise has also shown to reduce costs associated with
the disease by decreasing use of the health care system, in
particular unplanned hospitalizations due to exacerbation
of COPD [32].
Limitations to this study include the small patient
numbers but time and resource constraints did not allow
us to enroll more patients. Moreover, our primary study
goal was to evaluate the impact of urban heat stress on
patients with COPD. The strength of this study lies in
the use of tele-monitoring to obtain date stamped clin-
ical status and functional performance data during both
heat stress and thermal comfort days. Our COPD patients
were of stages GOLD II–IV and sufficiently ambulatory to
perform a 6MWT, thus our findings should not be
extrapolated onto COPD patients who are not fully
ambulatory, because they use oxygen therapy or who
have co-morbidities such as osteoarthritis or rheuma-
toid arthritis.
According to a report from the Center for Health and
the Global Environment at Harvard Medical School,
there will be an increase in the number, duration and in-
tensity of extreme weather events, including heat waves
[33]. The changing climate appears to show an increase
in temperature variance leading to more record hot days.
This will cause clinical status and quality of life to deteri-
orate in patients with COPD. Adaptation strategies
must be in place to protect vulnerable patients at risk for
heat stress in order to reduce poor outcome. These in-
clude, but are not limited to, tele-monitoring, patient
schooling about proper adaptive behavior during and
outside of heat stress, as well as necessary adjustments
in pharmacological therapy. These findings are prelim-
inary and must be confirmed in a larger patient
population.Conclusion
Heat stress negatively impacts clinical and functional sta-
tus in patients with COPD and makes patients more
vulnerable for disease related morbidity. Tele-monitoring
reduces exacerbation frequency and should be imple-
mented on top of regular patient care during periods of
prolonged heat exposure.
Abbreviations
COPD: Chronic obstructive pulmonary disease; GOLD: Global initiative for
obstructive lung disease; MMRC: Modified medical research council dyspnea
scale; SGRQ: Saint georges respiratory questionnaire; FEV1: Forced expiratory
volume in one second; PEF: Peak expiratory flow; BMI: Body mass index;
TG: Telegroup; CG: Controlgroup; 6MWT: 6-Minute walk test; CAT: COPD
assessment test; SpO2: Resting oxygen saturation; BODE: Body-mass index,
airflow obstruction, dyspnea, and exercise capacity index; Long AC: Long
acting anticholinergic; ICS/LABA: Fix combination of ICS/LABA.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ML coordinated and supervised the study, performed the statistical analysis
and drafted the manuscript; GD contributed to the statistical analysis,
discussion of results and draft of the manuscript; MG helped coordinate the
study and draft of the manuscript; UL contributed to study design,
coordination and draft of the manuscript; KM provided expert advice on
meteorological data and helped draft the manuscript; DS provided expert
advice on meteorological data and helped draft the manuscript; WE helped
conceive and design the study, provided expert advice on meteorological
data and helped draft the manuscript; CW conceived, designed and
supervised the study, contributed to the discussion of results and draft of
the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This study is funded by the German Ministry for Education and Research
(BMBF: NCT01LR0803L) and Deutsche Forschungsgemeinschaft Research Unit
1736 (DFG, Grant Number: SCHE 750/9-1) “Urban Climate Change and Heat
stress in mid-latitide cities in view of climate change (UCaHS) WI-1516/2-1”.
Author details
1Division of Pneumological Oncology and Transplantology, Charité
Universitätsmedizin Berlin, Berlin, Germany. 2Centre for Respiratory Medicine,
Royal Free & UCL Medical School, London, UK. 3Institut for Social Economy,
Leibniz-Zentrum für Agrarlandschaftsforschung e.V.; on behalf of the
KLIMZUG Research Group, Berlin, Germany. 4Department of Ecology,
Technische Universität Berlin; on behalf of the UCaSH Research Unit, Berlin,
Germany. 5Geography Department, Humboldt-Universität zu Berlin; on behalf
of the KLIMZUG Research Group, Berlin, Germany.
Received: 16 September 2013 Accepted: 15 November 2013
Published: 21 November 2013
Jehn et al. Environmental Health 2013, 12:99 Page 8 of 8
http://www.ehjournal.net/content/12/1/99References
1. Michelozzi P, Accetta G, De SM, D’Ippoliti D, Marino C, Baccini M, Biggeri A,
Anderson HR, Katsouyanni K, Ballester F, Bisanti L, Cadum E, Forsberg B,
Forastiere F, Goodman PG, Hojs A, Kirchmayer U, Medina S, Paldy A,
Schindler C, Sunyer J, Perucci CA: High temperature and hospitalizations
for cardiovascular and respiratory causes in 12 European cities. Am J
Respir Crit Care Med 2009, 179:383–389.
2. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L: Definition,
epidemiology and natural history of COPD. Eur Respir J 2007, 30:993–1013.
3. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R:
Quantifying physical activity in daily life with questionnaires and motion
sensors in COPD. Eur Respir J 2006, 27:1040–1055.
4. Michelozzi P, Kirchmayer U, Katsouyanni K, Biggeri A, McGregor G, Menne B,
Kassomenos P, Anderson HR, Baccini M, Accetta G, Analytis A, Kosatsky T:
Assessment and prevention of acute health effects of weather
conditions in Europe, the PHEWE project: background, objectives,
design. Environ Health 2007, 6:12.
5. Sprung CL: Heat stroke; modern approach to an ancient disease. Chest 1980,
77:461–462.
6. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y,
Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for
the diagnosis, management, and prevention of chronic obstructive
pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med
2007, 176:532–555.
7. Bouchama A, Dehbi M, Mohamed G, Matthies F, Shoukri M, Menne B:
Prognostic factors in heat wave related deaths: a meta-analysis. Arch Intern
Med 2007, 167:2170–2176.
8. Semenza JC, Rubin CH, Falter KH, Selanikio JD, Flanders WD, Howe HL,
Wilhelm JL: Heat-related deaths during the July 1995 heat wave in
Chicago. N Engl J Med 1996, 335:84–90.
9. Stafoggia M, Forastiere F, Agostini D, Caranci N, de’Donato F, Demaria M,
Michelozzi P, Miglio R, Rognoni M, Russo A, Perucci CA: Factors affecting
in-hospital heat-related mortality: a multi-city case-crossover analysis.
J Epidemiol Community Health 2008, 62:209–215.
10. Zanobetti A, O’Neill MS, Gronlund CJ, Schwartz JD: Summer temperature
variability and long-term survival among elderly people with chronic
disease. Proc Natl Acad Sci U S A 2012, 109:6608–6613.
11. Kenny GP, Yardley J, Brown C, Sigal RJ, Jay O: Heat stress in older
individuals and patients with common chronic diseases. CMAJ 2010,
182:1053–1060.
12. Takamata A, Ito T, Yaegashi K, Takamiya H, Maegawa Y, Itoh T, Greenleaf JE,
Morimoto T: Effect of an exercise-heat acclimation program on body fluid
regulatory responses to dehydration in older men. Am J Physiol 1999,
277:R1041–R1050.
13. Zappe DH, Bell GW, Swartzentruber H, Wideman RF, Kenney WL: Age and
regulation of fluid and electrolyte balance during repeated exercise
sessions. Am J Physiol 1996, 270:R71–R79.
14. Holguin F, Folch E, Redd SC, Mannino DM: Comorbidity and mortality in
COPD-related hospitalizations in the United States, 1979 to 2001.
Chest 2005, 128:2005–2011.
15. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE: Waging war on
physical inactivity: using modern molecular ammunition against an
ancient enemy. J Appl Physiol 2002, 93:3–30.
16. Bowles DK, Woodman CR, Laughlin MH: Coronary smooth muscle and
endothelial adaptations to exercise training. Exerc Sport Sci Rev 2000,
28:57–62.
17. Steiner MC, Morgan MD: Enhancing physical performance in chronic
obstructive pulmonary disease. Thorax 2001, 56:73–77.
18. Lin S, Hsu WH, Van Zutphen AR, Saha S, Luber G, Hwang SA: Excessive heat
and respiratory hospitalizations in New York State: estimating current
and future public health burden related to climate change. Environ Health
Perspect 2012, 120:1571–1577.
19. Meehl GA, Tebaldi C: More intense, more frequent, and longer lasting
heat waves in the 21st century. Science 2004, 305:994–997.
20. Global Initiative for Chronic Obstructiive Lung Disease (GOLD): Global
stategy for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease: revised 2011. 2011. Available from: http://www.goldcopd.
org/uploads/users/files/GOLD_Report_2011_Jan21.pdf.
21. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW:
American translation, modification, and validation of the St. George’s
Respiratory Questionnaire. Clin Ther 2000, 22:1121–1145.22. Jehn M, Schmidt-Trucksaess A, Schuster T, Hanssen H, Weis M, Halle M,
Koehler F: Accelerometer-based quantification of 6-minute walk test
performance in patients with chronic heart failure: applicability in
telemedicine. J Card Fail 2009, 15:334–340.
23. Zanobetti A, Bind MA, Schwartz J: Particulate air pollution and survival in
a COPD cohort. Environ Health 2008, 7:48.
24. Argaud L, Ferry T, Le QH, Marfisi A, Ciorba D, Achache P, Ducluzeau R,
Robert D: Short- and long-term outcomes of heatstroke following the
2003 heat wave in Lyon, France. Arch Intern Med 2007, 167:2177–2183.
25. Hoffmann B, Hertel S, Boes T, Weiland D, Jockel KH: Increased cause-specific
mortality associated with 2003 heat wave in Essen, Germany. J Toxicol
Environ Health A 2008, 71:759–765.
26. Jensen MH, Cichosz SL, Hejlesen OK, Toft E, Nielsen C, Grann O, Dinesen BI:
Clinical impact of home telemonitoring on patients with chronic
obstructive pulmonary disease. Telemed J e Health 2012, 18:674–678.
27. Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernández C, Alonso A,
del Pozo F, de Toledo P, Antó JM, Rodríguez-Roisín R, Decramer M:
Integrated care prevents hospitalisations for exacerbations in COPD
patients. Eur Respir J 2006, 28:123–130.
28. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P,
Nault D, Borycki E, Schwartzman K, Singh R, Collet JP: Reduction of hospital
utilization in patients with chronic obstructive pulmonary disease: a
disease-specific self-management intervention. Arch Intern Med 2003,
163:585–591.
29. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE: Systematic
review of the chronic care model in chronic obstructive pulmonary
disease prevention and management. Arch Intern Med 2007, 167:551–561.
30. Vitacca M, Bianchi L, Guerra A, Fracchia C, Spanevello A, Balbi B, Scalvini S:
Tele-assistance in chronic respiratory failure patients: a randomised
clinical trial. Eur Respir J 2009, 33:411–418.
31. Coventry PA, Hind D: Comprehensive pulmonary rehabilitation for
anxiety and depression in adults with chronic obstructive pulmonary
disease: systematic review and meta-analysis. J Psychosom Res 2007,
63:551–565.
32. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA: Cost effectiveness of
an outpatient multidisciplinary pulmonary rehabilitation program.
Thorax 2001, 56:779–784.
33. Epstein PR, Mills E: The Center for Health and the Global Environment. Boston,
MASS: Harvard Medical School; 2006.
doi:10.1186/1476-069X-12-99
Cite this article as: Jehn et al.: Tele-monitoring reduces exacerbation of
COPD in the context of climate change–a randomized controlled trial.
Environmental Health 2013 12:99.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
